Loading [MathJax]/jax/output/SVG/jax.js
Review Topical Sections

Biodegradable polymers in dental tissue engineering and regeneration

  • Received: 13 August 2018 Accepted: 18 October 2018 Published: 07 November 2018
  • Over the last decade, biodegradable polymers (BP) replaced traditional non-degradable materials in dental and maxillo-facial surgery, in particular for bone regeneration and periodontal care, due to their ability to break down and be absorbed by the body without producing harmful degradation products, along with their great potential for controlled drug delivery, wound management, dental restorations, and tissue engineering. This review described the physical–chemical characteristics of these materials, classified them based on their sensitivity on hydrolytic or enzyme degradation, and described their recent application in both restorative and regenerative dentistry.

    Citation: Raffaele Conte, Anna Di Salle, Francesco Riccitiello, Orsolina Petillo, Gianfranco Peluso, Anna Calarco. Biodegradable polymers in dental tissue engineering and regeneration[J]. AIMS Materials Science, 2018, 5(6): 1073-1101. doi: 10.3934/matersci.2018.6.1073

    Related Papers:

    [1] Saheb Pal, Nikhil Pal, Sudip Samanta, Joydev Chattopadhyay . Fear effect in prey and hunting cooperation among predators in a Leslie-Gower model. Mathematical Biosciences and Engineering, 2019, 16(5): 5146-5179. doi: 10.3934/mbe.2019258
    [2] Chunmei Zhang, Suli Liu, Jianhua Huang, Weiming Wang . Stability and Hopf bifurcation in an eco-epidemiological system with the cost of anti-predator behaviors. Mathematical Biosciences and Engineering, 2023, 20(5): 8146-8161. doi: 10.3934/mbe.2023354
    [3] Kawkab Al Amri, Qamar J. A Khan, David Greenhalgh . Combined impact of fear and Allee effect in predator-prey interaction models on their growth. Mathematical Biosciences and Engineering, 2024, 21(10): 7211-7252. doi: 10.3934/mbe.2024319
    [4] Sangeeta Kumari, Sidharth Menon, Abhirami K . Dynamical system of quokka population depicting Fennecaphobia by Vulpes vulpes. Mathematical Biosciences and Engineering, 2025, 22(6): 1342-1363. doi: 10.3934/mbe.2025050
    [5] Ranjit Kumar Upadhyay, Swati Mishra . Population dynamic consequences of fearful prey in a spatiotemporal predator-prey system. Mathematical Biosciences and Engineering, 2019, 16(1): 338-372. doi: 10.3934/mbe.2019017
    [6] Yuanfu Shao . Bifurcations of a delayed predator-prey system with fear, refuge for prey and additional food for predator. Mathematical Biosciences and Engineering, 2023, 20(4): 7429-7452. doi: 10.3934/mbe.2023322
    [7] Fang Liu, Yanfei Du . Spatiotemporal dynamics of a diffusive predator-prey model with delay and Allee effect in predator. Mathematical Biosciences and Engineering, 2023, 20(11): 19372-19400. doi: 10.3934/mbe.2023857
    [8] Hongqiuxue Wu, Zhong Li, Mengxin He . Dynamic analysis of a Leslie-Gower predator-prey model with the fear effect and nonlinear harvesting. Mathematical Biosciences and Engineering, 2023, 20(10): 18592-18629. doi: 10.3934/mbe.2023825
    [9] Jin Zhong, Yue Xia, Lijuan Chen, Fengde Chen . Dynamical analysis of a predator-prey system with fear-induced dispersal between patches. Mathematical Biosciences and Engineering, 2025, 22(5): 1159-1184. doi: 10.3934/mbe.2025042
    [10] Rongjie Yu, Hengguo Yu, Chuanjun Dai, Zengling Ma, Qi Wang, Min Zhao . Bifurcation analysis of Leslie-Gower predator-prey system with harvesting and fear effect. Mathematical Biosciences and Engineering, 2023, 20(10): 18267-18300. doi: 10.3934/mbe.2023812
  • Over the last decade, biodegradable polymers (BP) replaced traditional non-degradable materials in dental and maxillo-facial surgery, in particular for bone regeneration and periodontal care, due to their ability to break down and be absorbed by the body without producing harmful degradation products, along with their great potential for controlled drug delivery, wound management, dental restorations, and tissue engineering. This review described the physical–chemical characteristics of these materials, classified them based on their sensitivity on hydrolytic or enzyme degradation, and described their recent application in both restorative and regenerative dentistry.


    Interactions between the predators and the preys are diverse and complex in ecology. The predators increase the mortality rate of preys by direct predation. In existing literatures, many predator-prey models only involve direct predation for predator-prey interactions [1,2,3,4]. However, besides the population loss caused by direct predation, the prey will modify their behavior, psychology and physiology in response to the predation risk. This is defined as the fear effect by Cannon [5]. Zanette et al. [6] investigated the variation of song sparrows offspring reproduction when the sounds and calls of predators were broadcasted to simulate predation risk. They discovered that the fear effect alone can cause a significant reduction of song sparrows offspring reproduction. Inspired by this experimental result, Wang et al. [7] incorporated the fear effect into the predator-prey model. In their theoretical analysis, linear and Holling type Ⅱ functional response are chosen respectively. According to their results, the structure of the equilibria will not be affected by the fear effects, but the stability of equilibria and Hopf bifurcation are slightly different from models with no fear effects.

    Soon afterward, Wang and Zou [8] considered a model with the stage structure of prey (juvenile prey and adult prey) and a maturation time delay. Additionally, Wang and Zou [9] pointed out anti-predation behaviors will not only decrease offspring reproduction of prey but also increase the difficulty of the prey being caught. Based on this assumption, they derived an anti-predation strategic predator-prey model.

    Recently, the aforementioned ordinary or delayed differential equation models were extended to reaction diffusion equation [10,11,12]. Wang et al. [11] used several functional responses to study the effect of the degree of prey sensitivity to predation risk on pattern formation. Following this work, Wang et al. [10] introduced spatial memory delay and pregnancy delay into the model. Their numerical simulation presented the effect of some biological important variables, including the level of fear effect, memory-related diffusion, time delay induced by spatial memory and pregnancy on pattern formation. Moreover, Dai and Sun [13] incorporated chemotaxis and fear effect into predator-prey model, and investigated the Turing-Hopf bifurcation by selecting delay and chemotaxis coefficient as two analysis parameters.

    Denote by u1(x,t) and u2(x,t), the population of the prey and adult predator at location x and time t, respectively. We suppose juvenile predators are unable to prey on. By choosing simplest linear functional response in the model of Wang and Zou [7], the equation for prey population is given by

    tu1d1Δu1=u1(rg(K,u2)μ1mu1)pu1u2,

    where d1 is a diffusion coefficient for prey, μ1 is the mortality rate for prey, m is the intraspecies competition coefficient, p is predation rate, r is reproduction rate for prey and g(K,u2) represents the cost of anti-predator defense induced by fear with K reflecting response level. We assume g(K,u2) satisfies the following conditions.

    (H1) g(0,u2)=g(K,0)=1, limu2g(K,u2)=limKg(K,u2)=0, g(K,u2)K<0 and g(K,u2)u2<0.

    Considering the maturation period of the predator, we set b(x,t,a1) be the density of the predator at age a1, location x and time t. Establish the following population model with spatial diffusion and age-structure

    (a1+t)b(x,t,a1)=d(a1)Δb(x,t,a1)μ(a1)b(x,t,a1),b(x,t,0)=cpu1(x,t)u2(x,t), (1.1)

    where xΩ, a bounded spatial habitat with the smooth boundary Ω, t,a1>0, c is the conversion rate of the prey to predators, τ>0 be the maturation period of predator and age-specific functions

    d(a1)={d0, a1τ,d2, a1>τ,  μ(a1)={γ, a1τ,μ2, a1>τ,

    represent the diffusion rate and mortality rate at age a1, respectively. We introduce the total population of the matured predator as u2=τb(x,t,a1)da1. Thus, (1.1) together with b(x,t,)=0 yields

    tu2=d2Δu2+b(x,t,τ)μ2u2. (1.2)

    Let s1=ta1 and w(x,t,s1)=b(x,t,ts1). Along the characteristic line, solving (1.1) yields

    tw(x,t,s1)={d0Δw(x,t,s1)γw(x,t,s1),  xΩ, 0ts1τ,d2Δw(x,t,s1)μ2w(x,t,s1), xΩ, ts1>τ,w(x,s1,s1)=b(x,s1,0)=cpu1(x,s1)u2(x,s1), s10;  w(x,0,s1)=b(x,0,s1), s1<0.

    Assume linear operator d0Δγ with Neumann boundary conditions yields the C0 semigroups T1(t). Therefore,

    b(x,t,τ)=w(x,t,tτ)={T1(τ)b(,tτ,0), t>τ,T1(t)b(,0,τt), tτ.

    In particular, G(x,y,t) denotes the kernel function corresponding to T1(t). Thus

    b(x,t,τ)=T1(τ)b(,tτ,0)=cpΩG(x,y,τ)u1(y,tτ)u2(y,tτ)dy, t>τ.

    The above equation together with (1.2) yields a nonlocal diffusive predator-prey model with fear effect and maturation period of predators

    u1t=d1Δu1+u1(x,t)[rg(K,u2(x,t))μ1mu1(x,t)]pu1(x,t)u2(x,t),u2t=d2Δu2+cpΩG(x,y,τ)u1(y,tτ)u2(y,tτ)dyμ2u2(x,t). (1.3)

    Since the spatial movement of mature predators is much bigger than that of juvenile predators, we assume that diffusion rate of juvenile predators d0 approaches zero. Hence, the kernel function becomes G=eγτf(xy) with a Dirac-delta function f. Thus, the equation of u2(x,t) in (1.3) becomes

    u2t=d2Δu2+cpeγτΩf(xy)u1(y,tτ)u2(y,tτ)dyμ2u2(x,t).

    It follows from the properties of Dirac-delta function that

    Ωf(xy)u1(y,tτ)u2(y,tτ)dy=limϵ0Bϵ(x)f(xy)u1(y,tτ)u2(y,tτ)dy=u1(x,tτ)u2(x,tτ)limϵ0Bϵ(x)f(xy)dy=u1(x,tτ)u2(x,tτ)

    where Bϵ(x) is the open ball of radius ϵ centered at x. Therefore, model (1.3) equipped with nonnegative initial conditions and Neumann boundary conditions is

    u1(x,t)t=d1Δu1(x,t)+u1(x,t)[rg(K,u2(x,t))μ1mu1(x,t)]pu1(x,t)u2(x,t), xΩ,t>0,u2(x,t)t=d2Δu2(x,t)+cpeγτu1(x,tτ)u2(x,tτ)μ2u2(x,t), xΩ,t>0,u1(x,t)ν=u2(x,t)ν=0,xΩ,t>0,u1(x,ϑ)=u10(x,ϑ)0,u2(x,ϑ)=u20(x,ϑ)0,xΩ, ϑ[τ,0]. (1.4)

    If rμ1, then as t, we have (u1,u2)(0,0) for xΩ, namely, two species will extinct. Throughout this paper, suppose r>μ1, which ensures that the prey and predator will persist.

    This paper is organized as follows. We present results on well-posedness and uniform persistence of solutions and prove the global asymptotic stability of predator free equilibrium in Section 2. The nonexistence of nonhomogeneous steady state and steady state bifurcation are proven in Section 3. Hopf bifurcation analysis is carried out in Section 4. In Section 5, we conduct numerical exploration to illustrate some theoretical conclusions and further explore the dynamics of the nonlocal model numerically. We sum up our paper in Section 6.

    Denote by C:=C([τ,0],X2) the Banach space of continuous maps from [τ,0] to X2 equipped with supremum norm, where X=L2(Ω) is the Hilbert space of integrable function with the usual inner product. C+ is the nonnegative cone of C. Let u1(x,t) and u2(x,t) be a pair of continuous function on Ω×[τ,) and (u1t,u2t)C as (u1t(ϑ),u2t(ϑ))=(u1(,t+ϑ),u2(,t+ϑ)) for ϑ[τ,0]. By using [14,Corollary 4], we can prove model (1.4) exists a unique solution. Note (1.4) is mixed quasi-monotone [15], together with comparison principle implies that the solution of (1.4) is nonnegative.

    Lemma 2.1. For any initial condition (u10(x,ϑ),u20(x,ϑ))C+, model (1.4) possesses a unique solution (u1(x,t),u2(x,t)) on the maximal interval of existence [0,tmax). If tmax<, then lim supttmax(u1(,t)+u2(,t))=. Moreover, u1 and u2 are nonnegative for all (x,t)¯Ω×[τ,tmax).

    We next prove u1 and u2 are bounded which implies that tmax=.

    Theorem 2.2. For any initial condition φ=(u10(x,ϑ),u20(x,ϑ))C+, model (1.4) possesses a global solution (u1(x,t),u2(x,t)) which is unique and nonnegative for (x,t)¯Ω×[0,). If u10(x,ϑ)0(0),u20(x,ϑ)0(0), then this solution remains positive for all (x,t)¯Ω×(0,). Moreover, there exists a positive constant ξ independent of φ such that lim suptu1ξ, lim suptu2ξ for all xΩ.

    Proof. Consider

    w1t=d1Δw1+rw1μ1w1mw21, xΩ,t>0,w1ν=0, xΩ,t>0,  w1(x,0)=supϑ[τ,0]u10(x,ϑ), xΩ. (2.1)

    Clearly, w1(x,t) of (2.1) is a upper solution to (1.4) due to u1/td1Δu1+ru1μ1u1mu21. By using Lemma 2.2 in [16], (rμ1)/m of (2.1) is globally asymptotically stable in C(¯Ω,R+). This together with comparison theorem indicates

    lim suptu1limtw1=rμ1m  uniformly for  x¯Ω. (2.2)

    Thus, there exists ˜ξ>0 which is not dependent on initial condition, such that u1˜ξ for all t>0. T2(t) denotes the C0 semigroups yielded by d2Δμ2 with the Neumann boundary condition. Then from (1.4),

    u2=T2(t)u20(,0)+cpeγτtττT2(tτa)u1(,a)u2(,a)da.

    Let δ<0 be the principle eigenvalue of d2Δμ2 with the Neumann boundary condition. Then, T2(t)eδt. The above formula yields

    u2(,t)eδtu20(,0)+cpeγτ˜ξtττeδ(tτa)u2(,a)da,˜B1+t0˜B2u2(,a)da,

    by choosing constants ˜B1u2(,0)+cpτ˜ξsupa[τ,0]u2(,a) and ˜B2cp˜ξ. Using Gronwall's inequality yields u2(,t)˜B1e˜B2t for all 0t<tmax. Lemma 2.1 implies tmax=. So (u1,u2) is a global solution. Moreover, if u10(x,ϑ)0(0),u20(x,ϑ)0(0), then by [17,Theorem 4], this solution is positive for all t>0 and x¯Ω.

    We next prove (u1,u2) is ultimately bounded by a constant which is not dependent on the initial condition. Due to (2.2), there exist t0>0 and ξ0>0 such that u1(x,t)ξ0 for any t>t0 and x¯Ω. Let z(x,t)=cu1(x,tτ)+u2(x,t), μ=min{μ1,μ2} and I1=Ωz(x,t)dx. We integrate both sides of (1.4) and add up to obtain

    I1(t)Ω(c(rμ1)u1(x,tτ)μ2u2(x,t))dxcrξ0|Ω|μI1(t), tt0+τ.

    Comparison principle implies

    lim suptu21lim suptI1crξ0|Ω|/μ.

    Especially, there exist t1>t0 and ξ1>0 such that u21ξ1 for all tt1.

    Now, we define Vl(t)=Ω(u2(x,t))ldx with l1, and estimate the upper bound of V2(t). For t>t1, the second equation of (1.4) and Young's inequality yield

    12V2(t)d2Ω|u2|2dx+cpξ0Ωu2(x,tτ)u2(x,t)dxμ2V2(t)d2u222+cpξ02V2(tτ)+cpξ02V2(t).

    The Gagliardo-Nirenberg inequality states:

     ϵ>0, ˆc>0, s.t. P22ϵP22+ˆcϵn/2P21,  PW1,2(Ω).

    We obtain

    V2(t)C1+C2V2(tτ)(C2+C3)V2(t),

    where C1=ˆcϵn/212d2ξ21>0, C2=cpξ0>0 and C3=2(d2/ϵC2)>0 with small ϵ(0,d2/C2). Using comparison principle again yields lim suptV2(t)C1/C3, which implies there exist t2>t1 and ξ2>0 such that V2ξ2 for tt2.

    Let Ll=lim suptVl(t) with l1, we want to estimate L2l with the similar method of estimation for L2. Multiply the second equation in (1.4) by 2lv2l1 and integrate on Ω. Young's inequality implies

    V2l(t)2d2Ω|ul2|2dx+cpξ0V2l(tτ)+(2l1)cpξ0V2l(t).

    Then

    V2l(t)2d2ˆcϵn/21V2l(t)2d2ϵV2l(t)+cpξ0(V2l(tτ)+(2l1)V2l(t)),

    via Gagliardo-Nirenberg inequality. Since Ll=lim suptVl(t), there exists tl>0 such that Vl1+Ll when t>tl. Hence,

    V2l(t)2d2ˆcϵ(n/2+1)(1+Ll)22d2ϵV2l(t)+lC4(V2l(t)+V2l(tτ))

    with C4=2cpξ0. We choose ϵ1=(2C4+1)l/(2d2) and C5=2d2ˆc[(2C4+1)/(2d2)]n/2+1. Then for t>tl, we obtain

    V2l(t)C5ln/2+1(1+Ll)2+lC4V2l(tτ)(lC4+l)V2l(t).

    By comparison principle, the above inequality yields L2lC5ln/2(1+Ll)2, with a constant C5 which is not dependent on l and initial conditions. Finally, prove L2s< for all sN0. Let B=1+C5 and {bs}s=0 be an infinite sequence denoted by bs+1=B(1/2)(s+1)2sn((1/2)(s+2))bs with the first term b0=L1+1. Clearly, L2s(bs)2s and

    limslnbs=lnb0+lnB+n2ln2.

    Therefore,

    lim sups(L2s)(1/2)slimsbs=B(1+L1)2n/2B(1+ξ1)2n/2ξ:=max{B(ξ1+1)2n/2,(rμ1)/m}.

    The above inequality leads to lim suptu1ξ and lim suptu2ξ for all xΩ.

    In Theorem 2.2, we proved that the solution of model (1.4) is uniformly bounded for any nonnegative initial condition, this implies the boundedness of the population of two species. Clearly model (1.4) exists two constant steady states E0=(0,0) and E1=((rμ1)/m,0), where E0 is a saddle. Define the basic reproduction ratio [18] by

    R0=cpeγτ(rμ1)mμ2. (2.3)

    Thus model (1.4) possesses exactly one positive constant steady state E2=(u1,u2) if and only if R0>1, which is equivalent to cp(rμ1)>mμ2 and 0τ<τmax:=1γlncp(rμ1)mμ2. Here,

    u1=μ2eγτpc,  u2  satisfies  rg(K,u2)pu2=μ1+mu1.

    The linearization of (1.4) at the positive constant steady state (˜u1,˜u2) gives

    W/t=DΔW+L(Wt), (2.4)

    where domain Y:={(u1,u2)T:u1,u2C2(Ω)C1(ˉΩ),(u1)ν=(u2)ν=0 on Ω}, W=(u1(x,t),u2(x,t))T, D=diag(d1,d2) and a bounded linear operator L:CX2 is

    L(φ)=Mφ(0)+Mτφ(τ), for φC,

    with

    M=(rg(K,˜u2)μ12m˜u1p˜u2˜u1(rgu2(K,˜u2)p)0μ2), Mτ=(00cpeγτ˜u2cpeγτ˜u1).

    The characteristic equation of (2.4) gives

    ρηDΔηL(eρη)=0, for some ηY{0},

    or equivalently

    det(ρI+σnDMeρτMτ)=0, for nN0. (2.5)

    Here, σn is the eigenvalue of Δ in Ω with Neumann boundary condition with respect to eigenfunction ψn for all nN0, and

    0=σ0<σ1σ2σnσn+1  and  limnσn=. (2.6)

    Theorem 2.3. (i) The trivial constant steady state E0=(0,0) is always unstable.

    (ii) If R0>1, then E1=((rμ1)/m,0) is unstable, and model (1.4) possesses a unique positive constant steady state E2=(u1,u2).

    (iii) If R01, then E1 is globally asymptotically stable in C+.

    Proof. (ⅰ) Note, (2.5) at E0 takes form as (ρ+σnd1r+μ1)(ρ+σnd2+μ2)=0 for all nN0. Then rμ1>0 is a positive real eigenvalue, namely, E0 is always unstable.

    (ⅱ) The characteristic equation at E1 gives

    (ρ+σnd1+rμ1)(ρ+σnd2+μ2cpeγτrμ1meρτ)=0  for nN0. (2.7)

    Note that one eigenvalue ρ1=σnd1r+μ1 remains negative. Hence, we only need to consider the root distribution of the following equation

    ρ+σnd2+μ2cpeγτrμ1meρτ=0  for nN0. (2.8)

    According to [19,Lemma 2.1], we obtain that (2.8) exists an eigenvalue ρ>0 when R0>1, namely, E1 is unstable when R0>1.

    (ⅲ) By using [19,Lemma 2.1] again, any eigenvalue ρ of (2.8) satisfies Re(ρ)<0 when R0<1, namely, E1 is locally asymptotically stable when R0<1. Now, consider R0=1. 0 is an eigenvalue of (2.7) for n=0 and all other eigenvalues satisfy Re(ρ)<0. To prove the stability of E1, we shall calculate the normal forms of (1.4) by the algorithm introduced in [20]. Set

    Υ={ρC,ρ is the eigenvalue of equation (2.7) and Reρ=0}.

    Obviously, Υ={0} when R0=1. System (1.4) satisfies the non-resonance condition relative to Υ. Denote ¯u1=(rμ1)/m, and let w=(w1,w2)T=(¯u1u1,u2)T and (1.4) can be written as

    ˙wt=A0wt+F0(wt)  on  C.

    Here linear operator A0 is given by (A0φ)(ϑ)=(φ(ϑ)) when ϑ[τ,0) and

    (A0φ)(0)=(d1Δ00d2Δ)φ(0)+(r+μ1(prgu2(K,0))¯u10μ2)φ(0)+(000μ2)φ(τ),

    and the nonlinear operator F0 satisfies [F0(φ)](ϑ)=0 for τϑ<0. By Taylor expansion, [F0(φ)](0) can be written as

    [F0(φ)](0)=(mφ21(0)r¯u1gu2(K,0)φ22(0)/2+(rgu2(K,0)p)φ1(0)φ2(0)cpeγτφ1(τ)φ2(τ))+h.o.t. (2.9)

    Define a bilinear form

    β,α=Ω[α1(0)β1(0)+α2(0)β2(0)+μ20τβ2(ϑ+τ)α2(ϑ)dϑ]dx, βC([0,τ],X2), αC.

    Select α=(1,m/(prgu2(K,0)) and β=(0,1)T to be the right and left eigenfunction of A0 relative to eigenvalue 0, respectively. Decompose wt as wt=hα+δ and β,δ=0. Notice A0α=0 and β,A0δ=0. Thus,

    β,˙wt=β,A0wt+β,F0(wt)=β,F0(wt).

    Moreover,

    β,˙wt=˙hβ,α+β,˙δ=˙hβ,α.

    It follows from the above two equations that

    ˙hm(1+μ2τ)|Ω|prgu2(K,0)=β,F0(hα+δ)=ΩβT[F0(hα+δ)](0)dx=Ω[F0(hα+δ)]2(0)dx.

    When the initial value is a small perturbation of E1, then δ=O(h2), together with Taylor expansion yields

    [F0(hα+δ)]2(0)=cpeγτ(hα1(τ)+δ1(τ))(hα2(τ)+δ2(τ))=cpeγτmprgu2(K,0)h2+O(h3).

    Therefore, we obtain the norm form of (1.4) as follows

    ˙h=cpeγτ1+μ2τh2+O(h3). (2.10)

    Then for any positive initial value, the stability of zero solution of (2.10) implies E1 is locally asymptotically stable when R0=1.

    Next, it suffices to show the global attractivity of E1 in C+ when R01. Establish a Lyapunov functional V:C+R as

    V(ϕ1,ϕ2)=Ωϕ2(0)2dx+cpeγτrμ1mΩ0τϕ2(θ)2dθdx  for  (ϕ1,ϕ2)C+.

    Along solutions of (1.4), taking derivative of V(ϕ1,ϕ2) with respect to t yields

    dVdt2d2Ω|u2|2dx+Ω2cpeγτrμ1mu2(x,tτ)u2(x,t)2μ2u22(x,t)+cpeγτrμ1m[u22(x,t)u22(x,tτ)]dxΩ2μ2(R01)u22(x,t)dx0  if  R01.

    Note {E1} is the maximal invariant subset of dV/dt=0, together with LaSalle-Lyapunov invariance principle [21,22] implies E1 is globally asymptotically stable if R01.

    In Theorem 2.3, E0 is always unstable which suggests that at leat one species will persist eventually. Moreover, if R01, then E1 is globally asymptotically stable in C+, which implies that when the basic reproduction ratio is no more than one, the predator species will extinct and only the prey species can persist eventually. Next, we will prove the solution is uniformly persistent. Θt denotes the solution semiflow of (1.4) mapping C+ to C+; namely, Θtφ:=(u1(,t+),u2(,t+))C+. Set ζ+(φ)=t0{Θtφ} be the positive orbit and ϖ(φ) be the omega limit set of ζ+(φ). Denote

    Z:={(φ1,φ2)C+:φ10 and φ20}, Z:=C+Z={(φ1,φ2)C+:φ10 or φ20},

    Γ as the largest positively invariant set in Z, and Ws((˜u1,˜u2)) as the stable manifold associated with (˜u1,˜u2). We next present persistence result of model (1.4).

    Theorem 2.4. Suppose R0>1. Then there exists κ>0 such that lim inftu1(x,t)κ and lim inftu2(x,t)κ for any initial condition φZ and x¯Ω.

    Proof. Note Θt is compact, and Theorem 2.2 implies Θt is point dissipative. Then Θt possesses a nonempty global attractor in C+ [23]. Clearly, Γ={(φ1,φ2)C+:φ20}, and ϖ(φ)={E0,E1} for all φΓ. Define a generalized distance function ψ mapping C+ to R+ by

    ψ(φ)=minxˉΩ{φ1(x,0),φ2(x,0)}, φ=(φ1,φ2)C+.

    Following from strong maximum principle [24], ψ(Θtφ)>0 for all φZ. Due to ψ1(0,)Z, assumption (P) in [25,Section 3] holds. Then verify rest conditions in [25,Theorem 3].

    First, prove Ws(E0)ψ1(0,)=. Otherwise, there exists an initial condition φC+ with ψ(φ)>0, such that (u1,u2)E0 as t. Thus, for any sufficiently small ε1>0 satisfying rg(K,ε1)μ1>pε1, there exists t1>0 such that 0<u1,u2<ε1 for all xΩ and t>t1. Note that rg(K,0)μ1>0 and g(K,u2)/u2<0 ensure the existence of small ε1>0. Then the first equation in (1.4) and (H1) lead to

    tu1>d1Δu1+u1[(rg(K,ϵ1)μ1pϵ1)mu1],t>t1.

    Notice

    tˆu1d1Δˆu1=ˆu1[(rg(K,ϵ1)pϵ1μ1)mˆu1], xΩ,t>t1,νˆu1=0, xΩ,t>t1,

    has a globally asymptotically stable positive steady state (rg(K,ϵ1)μ1pϵ1)/m due to [16,Lemma 2.2], together with comparison principle yields limtu1limtˆu1>0. A contradiction is derived, so Ws(E0)ψ1(0,)=.

    Next check Ws(E1)ψ1(0,)=. If not, there exists φC+ with ψ(φ)>0 such that (u1,u2) converges to E1 as t. According to (2.2), for any small ε2>0 satisfying cpeγτ((rμ1)/mϵ2)>μ2, there exists t2>0 such that u1>(rμ1)/mε2 for all x¯Ω and t>t2τ. Note that R0>1 ensures the existence of ε2>0. Thus, the second equation of (1.4) yields

    tu2>d2Δu2+cpeγτ(rμ1mε2)u2(x,tτ)μ2u2(x,t), t>t2.

    In a similar manner, we derive limtu2(x,t)>0 by above inequality, cpeγτ((rμ1)/mϵ2)>μ2 and comparison principle. A contradiction yields again. Hence, it follows from Theorem 3 in [25] that, for any φC+, there exists κ>0 such that lim inftψ(Θtφ)κ uniformly for any x¯Ω.

    Theorem 2.4 implies that when the basic reproduction ratio is bigger than one, both the predator species and prey species will persist eventually. We next investigate the stability of E2. The corresponding characteristic equation at E2 gives

    ρ2+a1,nρ+a0,n+(b1,nρ+b0,n)eρτ=0, nN0, (2.11)

    with

    a1,n=σn(d1+d2)+μ2+mu1>0, a0,n=(σnd1+au1)(σnd2+μ2)>0,b1,n=μ2<0,  b0,n=μ2(σnd1+mu1+u2(rgu2(K,u2)p)).

    Characteristic equation (2.11) with τ=0 is

    ρ2+(a1,n+b1,n)ρ+a0,n+b0,n=0, nN0. (2.12)

    We observe that a0,n+b0,n=σnd2(σnd1+mu1)μ2u2(rgu2(K,u2)p)>0, and a1,n+b1,n=σn(d1+d2)+mu1>0 for all integer n0, which yields that any eigenvalue ρ of (2.12) satisfies Re(ρ)<0. Then, local asymptotic stability of E2 is derived when τ=0 which implies Turing instability can not happen for the non-delay system of (1.4). In addition, a0,n+b0,n>0 for any nN0 leads to that (2.11) can not have an eigenvalue 0 for any τ0. This suggests we look for the existence of simple ρ=±iδ (δ>0) for some τ>0. Substitute ρ=iδ into (2.11) and then

    Gn(δ,τ)=δ4+(a21,n2a0,nb21,n)δ2+a20,nb20,n=0,  nN0, (2.13)

    with

    a21,n2a0,nb21,n=(σnd1+mu1)2+(σnd2)2+2μ2σnd2>0,a0,n+b0,n=σnd2(σnd1+mu1)μ2u2(rgu2(K,u2)p)>0,a0,nb0,n=σ2nd1d2+σn(2μ2d1+mu1d2)+μ2(2mu1+u2(rgu2(K,u2)p)).

    Thus, a0,nb0,n0 for all nN0 is equivalent to

    (A0): 2mu1u2(prgu2(K,u2)).

    If (A0) holds, then (2.13) admits no positive roots, together with for τ=0, any eigenvalues ρ of (2.11) satisfies Re(ρ)<0, yields the next conclusion.

    Theorem 2.5. Suppose R0>1. Then, E2 is locally asymptotically stable provided that (A0) holds.

    Now, we consider positive nonhomogeneous steady states. The steady state (u1(x),u2(x)) of (1.4) satisfies the elliptic equation

    d1Δu1=rg(K,u2)u1μ1u1mu21pu1u2, xΩ,d2Δu2=cpeγτu1u2μ2u2, xΩ,νu1=νu2=0, xΩ. (3.1)

    From Theorem 2.3, all the solutions converge to E1 when R01 and the positive nonhomogeneous steady state may exist only if R0>1. Throughout this section, we assume that R0>1. In what follows, the positive lower and upper bounds independent of steady states for all positive solutions to (3.1) are derived.

    Theorem 3.1. Assume that R0>1. Then any nonnegative steady state of (3.1) other than (0,0), and ((rμ1)/m,0) should be positive. Moreover, there exist constants ¯B,B_>0 which depend on all parameters of (3.1) and Ω, such that B_u1(x),u2(x)¯B for any positive solution of (3.1) and x¯Ω.

    Proof. We first show any nonnegative solution (u1,u2) other than E0 and E1, should be u1>0 and u2>0 for all x¯Ω. To see this, suppose u2(x0)=0 for some x0¯Ω, then u2(x)0 via strong maximum principle and

    0d1Ω|(u1rμ1m)|2dx=Ωmu1(x)(u1(x)rμ1m)2dx0.

    Thus the above inequality implies u1(x)0 or u1(x)(rμ1)/m. Now, we assume u2>0 for all x¯Ω. Strong maximum principle yields u1>0 for all x¯Ω. Hence, u1>0 and u2>0 for all x¯Ω.

    We now prove u1 and u2 have a upper bound which is a positive constant. Since d1Δu1(x)(rμ1mu1(x))u1(x), we then obtain from Lemma 2.3 in [26] that u1(x)(rμ1)/m for any x¯Ω.

    By two equations in (3.1), we obtain

    Δ(d1cu1+d2u2)rc(rμ1)/mmin{μ1d1,μ2d2}(d1cu1+d2u2).

    By using [26,Lemma 2.3] again, we conclude

    u1(x),u2(x)¯B=rc(rμ1)mmin{cμ1,μ2,μ1d2/d1,μ2d1c/d2}.

    Next, we only need to prove u1(x) and u2(x) have a positive lower bound which is not dependent on the solution. Otherwise, there exists a positive steady states sequence (u1,n(x),u2,n(x)) such that either limnu1,n=0 or limnu2,n=0. Integrating second equation of (3.1) gives

    0=Ωu2,n(cpeγτu1,nμ2)dx. (3.2)

    If u1,n(x)0 as n, then cpeγτu1,n(x)μ2<μ2/2 for sufficiently large n, which yields u2,n(cpeγτu1,nμ2)<0, a contradiction derived. Thus, u2,n(x)0 as n holds. We then assume that (u1,n,u2,n)(u1,,0), as n where u1,0. Similarly, we obtain that either u1,0 or u1,(rμ1)/m. Obviously, u1,0 based on the above argument, thus u1,(rμ1)/m and limncpeγτu1,n(x)μ2=μ2(R01)>0. This again contradicts (3.2). Hence, we have shown u1(x) and u2(x) have a positive constant lower bound independent on the solution. Therefore, u1(x) and u2(x) have a uniform positive constant lower bound independent on the solution of (3.1) via Harnack's inequality [26,Lemma 2.2]. This ends the proof.

    Theorem 3.2. Suppose R0>1. There exists a constant χ>0 depending on r,μ1,p,c,γ,τ,μ2,g and σ1, such that if min{d1,d2}>χ then model (1.4) admits no positive spatially nonhomogeneous steady states, where σ1 is defined in (2.6).

    Proof. Denote the averages of the positive solution (u1,u2) of system (3.1) on Ω by

    ~u1=Ωu1(x)dx|Ω|  and  ~u2=Ωu2(x)dx|Ω|.

    By (2.2), we have u1(x)¯u1, where ¯u1=(rμ1)/m, which implies ~u1¯u1. Multiplying the first equation by ceγτ and adding two equations of (3.1) lead to

    (d1ceγτΔu1+d2Δu2)=ceγτ(rg(K,u2)u1μ1u1mu21)μ2u2.

    The integration of both sides for the above equation yields

    ~u2=ceγτμ2|Ω|Ω(rg(K,u2)u1μ1u1mu21)dx(rμ1)¯u1ceγτμ2:=Mv.

    It is readily seen that Ω(u1~u1)dx=Ω(u2~u2)dx=0. Note u1 and u2 are bounded by two constants ¯u1>0 and ¯u2:=rc¯u1/min{μ1d2/d1,μ2}>0 by Theorem 3.1. Denote Mf=maxu2[0,¯u2]|gu2(K,u2)| and we then obtain

    d1Ω|(u1~u1)|2dx=Ω(u1~u1)(rg(K,u2)u1μ1u1mu21)dxΩpu1u2(u1~u1)dx=Ω(u1~u1)(rg(K,u2)u1μ1u1mu21(rg(K,~u2)~u1μ1~u1m~u12))dx+Ωp(~u1~u2u1u2)(u1~u1)dx(rμ1+(rMf+p)¯u12)Ω(u1~u1)2dx+(rMf+p)¯u12Ω(u2~u2)2dx,
    d2Ω|(u2~u2)|2dx=Ω(cpeγτu1u2μ2u2)(u2~u2)dx=cpeγτΩ(u1u2~u1~u2)(u2~u2)dxΩμ2(u2~u2)2dxcpeγτΩMv2(u1~u1)2dx+cpeγτ(¯u1+Mv2)Ω(u2~u2)2dx.

    Set A1=(rμ1)+((rMf+p)¯u1+cpeγτMv)/2, and A2=((rMf+p)¯u1+cpeγτ(2¯u1+Mv))/2. Then, the above inequalities and Poincarˊe inequality yield that

    d1Ω|(u1~u1)|2dx+d2Ω|(u2~u2)|2dxχΩ(|(u1~u1)|2+|(u2~u2)|2)dx,

    with a positive constant χ=max{A1/σ1,A2/σ1} depending on r,f,μ1,p,c,γ,τ,μ2 and σ1. Hence, if χ<min{d1,d2}, then (u1~u1)=(u2~u2)=0, which implies (u1,u2) is a constant solution.

    Select u1:=ν as the bifurcation parameter and study nonhomogeneous steady state bifurcating from E. Let u2,ν satisfy rg(K,u2)pu2=μ1+mν, E2=(ν,u2,ν), and (ˆu1,ˆu2)=(u1ν,u2u2,ν). Drop ˆ. System (3.1) becomes

    H(ν,u1,u2)=(d1Δu1+(u1+ν)(rg(K,u2+u2,ν)μ1m(u1+ν)p(u2+u2,ν))d2Δu2+cpeγτ(u1+ν)(u2+u2,ν)μ2(u2+u2,ν))=0,

    for (ν,u1,u2)R+×Y with Y={(u1,u2):u1,u2H2(Ω),(u1)ν=(u2)ν=0, on Ω}. Calculating Frˊechet derivative of H gives

    D(u1,u2)H(ν,0,0)=(d1Δmνν(rgu2(K,u2,ν)p)cpeγτu2,νd2Δ).

    Then the characteristic equation follows

    ρ2+Pi(ν)ρ+Qi(ν)=0  for  iN0, (3.3)

    where

    Pi(ν)=mν+(d1+d2)σi,  Qi(ν)=d1d2σ2i+d2mνσiμ2u2,ν(rgu2(K,u2,ν)p).

    Obviously, Qi>0 and Pi>0 for all νR+ and iN0. Therefore, (3.3) does not have a simple zero eigenvalue. According to [4], we obtain the nonexistence of steady state bifurcation bifurcating at E2.

    Theorem 3.3. Model (1.4) admits no positive nonhomogeneous steady states bifurcating from E2.

    Next, the stability switches at E2 and existence of periodic solutions of (1.4) bifurcating from E2 are studied. Suppose R0>1, namely, cp(rμ1)>mμ2 and 0τ<τmax:=1γlncp(rμ1)mμ2 to guarantee the existence of E2.

    Recall the stability of E2 for τ=0 is proved and 0 is not the root of (2.11) for τ0. So, we only consider eigenvalues cross the imaginary axis to the right which corresponds to the stability changes of E2. Now, we shall consider the positive root of Gn(δ,τ). Clearly, there exists exactly one positive root of Gn(δ,τ)=0 if and only if a0,n<b0,n for nN0. More specifically,

    (A1): 2mu1<u2(prgu2(K,u2))

    is the sufficient and necessary condition to ensure G0(δ,τ) has exactly one positive zero. For some integer n1, the assumption (A1) is a necessary condition to guarantee Gn(δ,τ) exists positive zeros. Set

    Jn={τ:τ[0,τmax) satisfies a0,n(τ)<b0,n(τ)},  nN0. (4.1)

    Implicit function theorem implies Gn(δ,τ) has a unique zero

    δn(τ)=([b21,n+2a0,na21,n+(b21,n+2a0,na21,n)24(a20,nb20,n)]/2)

    which is a C1 function for τJn. Hence, iδn(τ) is an eigenvalue of (2.11), and δn(τ) satisfies

    sin(δn(τ)τ)=δn(μ2δ2n+μ2a0,n+b0,na1,n)μ22δ2n+b20,n:=h1,n(τ),cos(δn(τ)τ)=b0,n(δ2na0,n)+a1,nμ2δ2nμ22δ2n+b20,n:=h2,n(τ), (4.2)

    for nN0. Let

    ϑn(τ)={arccosh2,n(τ), if δ2n<a0,n+b0,na1,n/μ2,2πarccosh2,n(τ), if δ2na0,n+b0,na1,n/μ2,

    which is the unique solution of sinϑn=h1,n and cosϑn=h2,n and satisfies ϑn(τ)(0,2π] for τIn.

    According to [3,27], we arrive at the next properties.

    Lemma 4.1. Suppose that R0>1 and (A1) holds.

    (i) There exists a nonnegative integer M1 such that Jn for 0nM1, with JM1JM11J1J0, and Jn= for n1+M1, where Jn is defined in (4.1).

    (ii) Define

    Skn(τ)=δn(τ)τϑn(τ)2kπ  for integer 0nM1, kN0, and τJn. (4.3)

    Then, S00(0)<0; for 0nM1 and kN0, we have limτˆτnSkn(τ)=(2k+1)π, where ˆτn=supJn; Sk+1n(τ)<Skn(τ) and Skn(τ)>Skn+1(τ).

    (iii) For each integer n[0,N1] and some kN0, Skn(τ) has one positive zero ¯τnJn if and only if (2.11) has a pair of eigenvalues ±iδn(¯τn). Moreover,

    Sign(Reλ(¯τn))=Sign((Skn)(¯τn)). (4.4)

    When (Skn)(¯τn)<0, ±iδn(¯τn) cross the imaginary axis from right to left at τ=¯τn; when (Skn)(¯τn)>0, ±iδn(¯τn) cross the imaginary axis from left to right.

    If supτI0S000, then Skn<0 in Jn holds for any 0nM1 and kN0; or only S00 has a zero with even multiplicity in J0 and Skn<0 for any positive integers n and k. Therefore, E2 is locally asymptotically stable for τ[0,τmax). The following assumption ensures Hopf bifurcation may occur at E2.

    (A2) supτJ0S00(τ)>0 and Skn(τ) has at most two zeros (counting multiplicity) for integer 0nM1 and kN0.

    Note supτJnS0n is strictly decreasing in n due to Lemma 4.1. It then follows from (A2), and Skn(0)<S00(0)<0, limτˆτnSkn(τ)<0 for any integer 0nM1 and kN0, that we can find two positive integers

    M={n[0,M1]: supS0n>0 and supS0n+10}0, (4.5)

    and

    Kn={j1: supSj1n>0 and supSjn0}1, for any integer 0nM. (4.6)

    Then Skn(τ) admits two simple zeros τkn and τ2Knk1n for k[0,Kn1] and no zeros for kKn. The above analysis, together with Lemma 4.1(ⅲ), yields the next result.

    Lemma 4.2. Suppose R0>1 and (A1) and (A2) hold. Let Skn(τ), M and Kn be defined in (4.3), (4.5) and (4.6).

    (i) For integer n[0,M], there are 2Kn simple zeros τjn (0j2Kn1) of Sin(τ) (0iKn1), 0<τ0n<τ1n<τ2n<<τ2Kn1n<ˆτn, and dSin(τin)/dτ>0 and dSin(τ2Kni1n)/dτ<0 for each 0iKn1.

    (ii) If there exist exactly two bifurcation values τjn1=τin2:=τ with n1n2 and (n1,j),(n2,i)[0,M]×[0,2Kn1], then the double Hopf bifurcation occurs at E2 when τ=τ.

    Collect all values τjn with 0nM and 0j2Kn1 in a set. To ensure Hopf bifurcation occurs, remove values which appear more than once. The new set becomes

    Σ={τ0,τ1,,τ2L1}, with τi<τj if i<j and 1LMn=0Kn. (4.7)

    Lemma 4.1(ⅱ) implies S00(τ) exists two simple zeros τ0<τ2L1. When τ=τi with 0i2L1, the Hopf bifurcation occurs at E2. Moreover, E2 is locally asymptotically stable for τ[0,τ0)(τ2L1,τmax) and unstable for τ(τ0,τ2L1). Define

    Σ0={τΣ:Sj0(τ)=0 for integer 0jK0}. (4.8)

    Theorem 4.3. Suppose R0>1. Let Jn, Skn(τ), Σ and Σ0 be defined in (4.1), (4.3), (4.7) and (4.8), respectively.

    (i) E2 is locally asymptotically stable for all τ[0,τmax) provided that either J0= or supτJ0S00(τ)0.

    (ii) If (A1) and (A2) hold, then a Hopf bifurcation occurs at E2 when τΣ. E2 is locally asymptotically stable for τ[0,τ0)(τ2L1,τmax), and unstable for τ(τ0,τ2L1). Further, for τΣΣ0, the bifurcating periodic solution is spatially nonhomogeneous; for τΣ0, the bifurcating periodic solution is spatially homogeneous.

    Next investigate the properties of bifurcating periodic solutions by global Hopf bifurcation theorem [28]. Set y(t)=(y1(t),y2(t))T=(u1(,τt)u1,u2(,τt)u2)T and write (1.4) as

    y(t)=Ay(t)+Z(yt,τ,Q), (t,τ,Q)R+×[0,τmax)×R+, ytC([1,0],X2), (4.9)

    where yt(ν)=y(t+ν) for ν[1,0], A=diag(τd1Δτμ1,τd2Δτμ2) and

    Z(yt)=τ((y1t(0)+u1)(rg(K,y2t(0)+u2)m(y1t(0)+u1)p(y2t(0)+u2))μ1u1cpeγτ(y1t(1)+u1)(y2t(1)+u2)μ2u2).

    {Ψ(t)}t0 denotes the semigroup yielded by A in Ω, with Neumann boundary condition. Clearly, limtΨ(t)=0. The solution of (4.9) can be denoted by

    y(t)=Ψ(t)y(0)+t0Ψ(tσ)Z(yσ)dσ. (4.10)

    If y(t) is a aperiodic solution of (4.9), then (4.10) yields

    y(t)=tΨ(ts)Z(yσ)dσ, (4.11)

    since Ψ(t+na)y(0)0 as n. Hence we only need to consider (4.11). The integral operator of (4.11) is differentiable, completely continuous, and G-equivariant by [24,Chapter 6.5]. The condition min{d1,d2}>χ ensures (1.4) admits exactly one positive steady state E2. Using a similar argument as in [29,Section 4.2], (H1)(H4) in [24,Chapter 6.5] hold and we shall study the periodic solution.

    Lemma 4.4. Suppose R0>1, then all nonnegative periodic solutions of (4.9) satisfies κu1(x,t),u2(x,t)ξ for all (x,t)¯Ω×R+, where ξ and κ are defined in Theorems 2.2 and 2.4, respectively.

    Lemma 4.4 can be obtained by Theorems 2.2 and 2.4. We further assume

    (A3): g(K,u2)g(K,u2)u1u1mr0  for  u1[κ,rμ1m]  and  u2[κ,ξ].

    This technical condition is used to exclude the τperiodic solutions. Note assumption (A3) holds when K=0. This, together with that (g(K,u2)g(K,u2))/(u1u1) is continuous in K, implies there exists ε>0 such that (A3) holds for 0K<ε, that is, (A3) holds for the model (1.4) with weak fear effect.

    Lemma 4.5. Assume that R0>1 and (A3) holds, then model (1.4) admits no nontrivial τperiodic solution.

    Proof. Otherwise, let (u1,u2) be the nontrivial τperiodic solution, that is, (u1(x,tτ),u2(x,tτ))=(u1(x,t),u2(x,t)). Thus, we have

    tu1=d1Δu1+u1(rg(K,u2)μ1mu1pu2), xΩ,t>0,tu2=d2Δu2+cpeγτu1u2μ2u2, xΩ,t>0,νu1=νu2=0,xΩ,t>0,u1(x,ϑ)=u10(x,ϑ)0,u2(x,ϑ)=u20(x,ϑ)0,xΩ,ϑ[τ,0]. (4.12)

    Claim

    (u1,u2)E2  as  t.

    To see this, establish the Lyapunov functional L1:C(ˉΩ,R+×R+)R,

    L1(ϕ1,ϕ2)=Ω(ceγτ(ϕ1u1lnϕ1)+(ϕ2u2lnϕ2))dx for (ϕ1,ϕ2)C(ˉΩ,R+×R+).

    Along the solution of system (4.12), the time derivative of L1(ϕ1,ϕ2) is

    dL1dt=Ω[d1μ2|u1|2pu21d2u2|u2|2u22+r(u1u1)2(g(K,u2)g(K,u2)u1u1mr)]dx.

    The assumption (A3) ensures dL1/dt0 for all (u1,u2)C(ˉΩ,R+×R+). The maximal invariant subset of dL1/dt=0 is {E2}. Therefore, E2 attracts all positive solution of (4.12) by LaSalle-Lyapunov invariance principle [21,22] which excludes the nonnegative nontrivial τperiodic solution.

    To obtain the nonexistence of τperiodic solution for model (1.4), we must use the condition (A3) which is very restrictive. However, in numerical simulations, Lemma 4.5 remains true even (A3) is violated. Thus, we conjecture the nonexistence of τ-periodic solution for (1.4).

    In the beginning of this section, when τ=τi with 0i2L1, ±iδn(τi) are a pair of eigenvalues of (2.11). Give the next standard notations:

    (i) For 0i2L1, (E2,τi,2π/(δn(τi)τi)) is an isolated singular point.

    (ii) Γ=Cl{(y,τ,Q)X2×R+×R+: y is the nontrivial Q-periodic solution of (4.9)} is a closed subset of X2×R+×R+.

    (iii) For 0i2L1, Ci(E2,τi,Qi) is the connected component of (E2,τi,Qi) in Γ.

    (iv) For integer 0kmaxn[0,M]Kn1, let ΣkH={τΣ:Skn(τ)=0 for integer 0nM}.

    We are ready to present a conclusion on the global Hopf branches by a similar manner in [30,Theorem 4.12].

    Theorem 4.6. Assume R0>1, min{d1,d2}>χ and (A1)(A3) hold. Then we have the following results.

    (i) The global Hopf branch Ci(E2,τi,Qi) is bounded for τiΣkH with k1 and i[0,2L1].

    (ii) For any τ(minkΣkH,maxkΣkH), model (1.4) possesses at least one periodic solution.

    (iii) For τi1Σk1H, τi2Σk2H with i1,i2[0,2L1] and k1,k2[0,maxn[0,M]Kn1], we have Ci1(E2,τi1,Qi1)Ci2(E2,τi2,Qi2)= if k1k2.

    To verify obtained theoretical results, the numerical simulation is presented in this part. We choose the fear effect function as g(K,u2)=eKu2 and let

    Ω=(0,2π),d1=d2=1,r=8,μ1=0.1,a=0.2,p=1,γ=0.3,μ2=0.2,c=0.1.

    Figure 1 shows the existence and stability of E0, E1 and E2, and Hopf bifurcation curve of model (1.4) in Kτ plane. Above the line τ=τmax, E2 does not exist, E1 is globally asymptotically stable and E0 is unstable; Below the line τ=τmax, there exist three constant steady states E0,E1 and E2. In the region which is bounded by τ=τmax and 2mu1+u2(rgu2(K,u2)p)=0, no Hopf bifurcation occurs and E2 is stable. In the region which is bounded by τ=τ0 and τ=τ1, there exist periodic solutions through Hopf bifurcation bifurcating at E2

    Figure 1.  Basic dynamics of model (1.4) in different regions with Kτ plane.

    Fix K=1.07, then by simple calculation, we have τmax9.944, τ00.85, τ13.55, J0=[0,5.25], J1=[0,3.05], Jn= for n2, supτJ0S00>0 and supτJ1S01<0. Thus, all Hopf bifurcation values τ0 and τ1 are the all zeros of Sk0(τ) for integer k0. We summarize the dynamics of model (1.4) as follows.

    (i) For τ[τmax,), we obtain E1 is globally asymptotically stable and E0 is unstable, see Figure 2(a).

    Figure 2.  (a) τ=10>τmax, E1 is globally asymptotically stable. (b) τ=0.5(0,τ0), E2 is locally asymptotically stable. (c) τ=2(τ0,τ1), a homogeneous periodic solution emerges.

    (ii) For τ(0,τ0)(τ1,τmax), we obtain E2 is locally asymptotically stable, and two constant steady state E0 and E1 are unstable, as shown in Figure 2(b).

    (iii) For τ(τ0,τ1), we obtain E0,E1 and E2 are unstable, a periodic solution bifurcates from E2, as shown in Figure 2(c). Further, a Hopf bifurcation occurs at E2 when τ=τ0,and τ1.

    Next, we explore the global Hopf branches by choosing Ω=(0,4π) and

    d1=1,d2=1,r=10,μ1=5,a=0.4,p=1,γ=0.05,μ2=4.75,c=2.5,K=0.4. (5.1)

    As shown in Figure 3, we collect all zeros of Skn(τ) for nonnegative n,k in set Bi with i=0,1,2,3, namely,

    B0={0.06,1.88,3.86,6.14,9.54,11.8,13.36,13.8,13.98,14.04},B1={0.08,1.96,4.04,6.56,12.36,13.01,13.25,13.35},B2={0.15,2.31,4.96,10.16,10.85,11.07}, B3={0.39,6.45}.
    Figure 3.  The graphs of Skn(τ) with integers 0n3 and 0k4.

    From Theorem 4.3, E2 is locally asymptotically stable when τ(0,0.06)(14.04,τmax) and unstable when τ(0.06,14.04), at least one periodic solution emerges for τ(0.06,14.04). Moreover, a spatially homogeneous periodic solution bifurcates from τB0, see Figure 4(a); a spatially nonhomogeneous periodic solution bifurcates from τB1B2B3, see Figure 4(b).

    Figure 4.  (a) τ=1.88B0, the bifurcating periodic solution is spatially homogeneous. (b) τ=2.68(τ4,τ5), the bifurcating periodic solution is spatially nonhomogeneous.

    In model (1.3), the kernel function takes form as G=eγτf(xy) by reasonable assumptions and our theoretical results are derived by choosing f(xy) as Dirac-delta function. Next, we choose

    f=e2|xy|2Ωe2|xy|2dy. (5.2)

    Here, f is the truncated normal distribution. Clearly, Ωf(xy)dy=1. Let Ω=(0,4π) and the parameter values chosen according to (5.1). As shown in Figure 5, when τ=1.03, a stable nonhomogeneous periodic solution emerges; when τ=1.5, a homogeneous periodic solution emerges; when τ=16, the positive constant steady state is stable. Numerical simulation suggests nonlocal interaction can produce more complex dynamics.

    Figure 5.  For the nonlocal model (1.3) with G defined in (5.2), delay τ induces different dynamics.

    We formulate an age-structured predator-prey model with fear effect. For R01, the global asymptotic stability for predator-free constant steady state is proved via Lyapunov-LaSalle invariance principle. For R0>1, we prove the nonexistence of spatially nonhomogeneous steady states and exclude steady state bifurcation. Finally, we carry out Hopf bifurcation analyses and prove global Hopf branches are bounded.

    Our theoretical results are obtained by choosing a special kernel function in model (1.3). However, in numerical results, we explore rich dynamics when the nonlocal interaction is incorporated into the delayed term. The theoretical results concerning the nonlocal model are left as an open problem.

    H. Shu was partially supported by the National Natural Science Foundation of China (No. 11971285), the Fundamental Research Funds for the Central Universities (No. GK202201002), the Natural Science Basic Research Program of Shaanxi (No. 2023-JC-JQ-03), and the Youth Innovation Team of Shaanxi Universities. W. Xu was partially supported by a scholarship from the China Scholarship Council while visiting the University of New Brunswick. P. Jiang was partially supported by the National Natural Science Foundation of China (No. 72274119).

    The authors declare no conflicts of interest in this paper.

    [1] Holtfreter B, Kocher T, Hoffmann T, et al. (2010) Prevalence of periodontal disease and treatment demands based on a German dental survey (DMS IV). J Clin Periodontol 37: 211–219. doi: 10.1111/j.1600-051X.2009.01517.x
    [2] Fujita T, Yamamoto S, Ota M, et al. (2011) Coverage of gingival recession defects using guided tissue regeneration with and without adjunctive enamel matrix derivative in a dog model. Int J Periodont Rest 31: 247–253.
    [3] Sun HH, Qu TJ, Zhang XH, et al. (2012) Designing biomaterials for in situ periodontal tissue regeneration. Biotechnol Progr 28: 3–20. doi: 10.1002/btpr.698
    [4] Lloyd AW (2002) Interfacial bioengineering to enhance surface biocompatibility. Med Device Technol 13: 18–21.
    [5] Schakenraad JM, Hardonk MJ, Feijen J, et al. (1990) Enzymatic activity toward poly(L-lactic acid) implants. J Biomed Mater Res 24: 529–545. doi: 10.1002/jbm.820240502
    [6] Finer Y, Santerre JP (2004) Salivary esterase activity and its association with the biodegradation of dental composites. J Dent Res 83: 22–26. doi: 10.1177/154405910408300105
    [7] Rokaya D, Srimaneepong V, Sapkota J, et al. (2018) Polymeric materials and films in dentistry: An overview. J Adv Res 14: 25–34. doi: 10.1016/j.jare.2018.05.001
    [8] Yuan W, Ji J, Fu J, et al. (2008) A facile method to construct hybrid multilayered films as a strong and multifunctional antibacterial coating. J Biomed Mater Res B 85: 556–563.
    [9] Travan A, Marsich E, Donati I, et al. (2011) Silver–polysaccharide nanocomposite antimicrobial coatings for methacrylic thermosets. Acta Biomater 7: 337–346. doi: 10.1016/j.actbio.2010.07.024
    [10] Mironov V, Visconti RP, Markwald RR (2004) What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin Biol Th 4: 773–781.
    [11] Rajeswari R, Clarisse CHN, Susan L, et al. (2012) Biomimetic surface modification of titanium surfaces for early cell capture by advanced electrospinning. Biomed Mater 7: 015001. doi: 10.1088/1748-6041/7/1/015001
    [12] Riccitiello F, De Luise A, Conte R, et al. (2018) Effect of resveratrol release kinetic from electrospun nanofibers on osteoblast and osteoclast differentiation. Eur Polym J 99: 289–297. doi: 10.1016/j.eurpolymj.2017.12.035
    [13] Coulembier O, Degée P, Hedrick JL, et al. (2006) From controlled ring-opening polymerization to biodegradable aliphatic polyester: Especially poly(β-malic acid) derivatives. Prog Polym Sci 31: 723–747. doi: 10.1016/j.progpolymsci.2006.08.004
    [14] Maurus PB, Kaeding CC (2004) Bioabsorbable implant material review. Oper Techn Sport Med 12: 158–160. doi: 10.1053/j.otsm.2004.07.015
    [15] Gunatillake P, Mayadunne R, Adhikari R (2006) Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 12: 301–347. doi: 10.1016/S1387-2656(06)12009-8
    [16] Katz AR, Turner RJ (1970) Evaluation of tensile and absorption properties of polyglycolic acid sutures. Surg Gynecol Obstet 131: 701–716.
    [17] Reed TM (1999) Allofix freeze-dried cortical bone pins as an alternative to synthetic absorbable polymeric pins: a preliminary study in short Z bunionectomies. J Foot Ankle Surg 38: 14–23. doi: 10.1016/S1067-2516(99)80083-0
    [18] Knecht S, Erggelet C, Endres M, et al. (2007) Mechanical testing of fixation techniques for scaffold-based tissue-engineered grafts. J Biomed Mater Res B 83: 50–57.
    [19] Frisbie DD, Lu Y, Kawcak CE, et al. (2009) In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. Am J Sport Med 37: 71–80. doi: 10.1177/0363546509348478
    [20] Xu L, Cao D, Liu W, et al. (2010) In vivo engineering of a functional tendon sheath in a hen model. Biomaterials 31: 3894–3902. doi: 10.1016/j.biomaterials.2010.01.106
    [21] Sayasneh A, Johnson H (2010) Risk factors for mesh erosion complicating vaginal reconstructive surgery. J Obstet Gynaecol 30: 721–724. doi: 10.3109/01443615.2010.501921
    [22] Aysan E, Bektas H, Ersoz F, et al. (2010) A novel colonic anastomosis technique involving fixed polyglycolic acid mesh. Int J Clin Exp Med 3: 341–346.
    [23] Dai T, Jiang Z, Li S, et al. (2010) Reconstruction of lymph vessel by lymphatic endothelial cells combined with polyglycolic acid scaffolds: a pilot study. J Biotechnol 150: 182–189.
    [24] Abbushi A, Endres M, Cabraja M, et al. (2008) Regeneration of intervertebral disc tissue by resorbable cell-free polyglycolic acid-based implants in a rabbit model of disc degeneration. Spine 33: 1527–1532. doi: 10.1097/BRS.0b013e3181788760
    [25] Ohara T, Itaya T, Usami K, et al. (2010) Evaluation of scaffold materials for tooth tissue engineering. J Biomed Mater Res A 94: 800–805.
    [26] Chang HH, Wang YL, Chiang YC, et al. (2014) A novel chitosan-γPGA polyelectrolyte complex hydrogel promotes early new bone formation in the alveolar socket following tooth extraction. PLoS One 9: e92362. doi: 10.1371/journal.pone.0092362
    [27] Middleton JC, Tipton AJ (2000) Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21: 2335–2346. doi: 10.1016/S0142-9612(00)00101-0
    [28] Suuronen R, Pohjonen T, Hietanen J, et al. (1998) A 5-year in vitro and in vivo study of the biodegradation of polylactide plates. J Oral Maxil Surg 56: 604–614. doi: 10.1016/S0278-2391(98)90461-X
    [29] Loo JS, Ooi CP, Boey FY (2005) Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. Biomaterials 26: 1359–1367. doi: 10.1016/j.biomaterials.2004.05.001
    [30] Shim IK, Jung MR, Kim KH, et al. (2010) Novel three-dimensional scaffolds of poly(L-lactic acid) microfibers using electrospinning and mechanical expansion: Fabrication and bone regeneration. J Biomed Mater Res B 95: 150–160.
    [31] Tanaka Y, Yamaoka H, Nishizawa S, et al. (2010) The optimization of porous polymeric scaffolds for chondrocyte/atelocollagen based tissue-engineered cartilage. Biomaterials 31: 4506–4516. doi: 10.1016/j.biomaterials.2010.02.028
    [32] Inui A, Kokubu T, Makino T, et al. (2010) Potency of double-layered poly L-lactic acid scaffold in tissue engineering of tendon tissue. Int Orthop 34: 1327–1332. doi: 10.1007/s00264-009-0917-8
    [33] Wang HB, Mullins ME, Cregg JM, et al. (2010) Varying the diameter of aligned electrospun fibers alters neurite outgrowth and Schwann cell migration. Acta Biomater 6: 2970–2978. doi: 10.1016/j.actbio.2010.02.020
    [34] Francois S, Chakfe N, Durand B, et al. (2009) A poly(L-lactic acid) nanofibre mesh scaffold for endothelial cells on vascular prostheses. Acta Biomater 5: 2418–2428. doi: 10.1016/j.actbio.2009.03.013
    [35] Tang L, Zhao C, Xiong Y, et al. (2010) Preparation, antibacterial properties and biocompatibility studies on vancomycin-poly(D,L)-lactic loaded plates. Int Orthop 34: 755–759. doi: 10.1007/s00264-009-0808-z
    [36] Carletti E, Endogan T, Hasirci N, et al. (2011) Microfabrication of PDLLA scaffolds. J Tissue Eng Regen M 5: 569–577. doi: 10.1002/term.349
    [37] Lee SH, Kim IY, Song WS (2014) Biodegradation of polylactic acid (PLA) fibers using different enzymes. Macromol Res 22: 657–663. doi: 10.1007/s13233-014-2107-9
    [38] Tomlin EM, Nelson SJ, Rossmann JA (2014) Ridge preservation for implant therapy: a review of the literature. Open Dent J 8: 66–76. doi: 10.2174/1874210601408010066
    [39] Thomas N, Sanil G, Rajmohan G, et al. (2011) Fabrication and anti-microbial evaluation of drug loaded polylactide space filler intended for ridge preservation following tooth extraction. J Indian Soc Periodontol 15: 260–264. doi: 10.4103/0972-124X.85671
    [40] Serino G, Biancu S, Iezzi G, et al. (2003) Ridge preservation following tooth extraction using a polylactide and polyglycolide sponge as space filler: a clinical and histological study in humans. Clin Oral Implan Res 14: 651–658. doi: 10.1034/j.1600-0501.2003.00970.x
    [41] Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3: 1377–1397. doi: 10.3390/polym3031377
    [42] Conn Jr. J, Oyasu R, Welsh M, et al. (1974) Vicryl (polyglactin 910) synthetic absorbable sutures. Am J Surg 128: 19–23. doi: 10.1016/0002-9610(74)90228-1
    [43] Liu J, Qiu Z, Wang S, et al. (2010) A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed Mater 5: 065002. doi: 10.1088/1748-6041/5/6/065002
    [44] Ye M, Kim S, Park K (2010) Issues in long-term protein delivery using biodegradable microparticles. J Control Release 146: 241–260. doi: 10.1016/j.jconrel.2010.05.011
    [45] Jiang W, Schwendeman SP (2008) Stabilization of tetanus toxoid encapsulated in PLGA microspheres. Mol Pharmaceut 5: 808–817. doi: 10.1021/mp800027f
    [46] Jhunjhunwala S, Raimondi G, Thomson AW, et al. (2009) Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release 133: 191–197. doi: 10.1016/j.jconrel.2008.10.011
    [47] Vega E, Gamisans F, Garcia ML, et al. (2008) PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci 97: 5306–5317. doi: 10.1002/jps.21383
    [48] Eperon S, Bossy-Nobs L, Petropoulos IK, et al. (2008) A biodegradable drug delivery system for the treatment of postoperative inflammation. Int J Pharmaceut 352: 240–247. doi: 10.1016/j.ijpharm.2007.10.054
    [49] Murata N, Takashima Y, Toyoshima K, et al. (2008) Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release 126: 246–254. doi: 10.1016/j.jconrel.2007.11.017
    [50] Levin BP (2013) Alveolar ridge augmentation: combining bioresorbable scaffolds with osteoinductive bone grafts in atrophic sites. A follow-up to an evolving technique. Compend Contin Educ Dent 34: 178–186.
    [51] Hassan KS (2009) Autogenous bone graft combined with polylactic polyglycolic acid polymer for treatment of dehiscence around immediate dental implants. Oral Surg Oral Med O 108: e19–e25.
    [52] Jones AA, Buser D, Schenk R, et al. (2006) The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 77: 1184–1193. doi: 10.1902/jop.2006.050337
    [53] Wu Z, Liu C, Zang G, et al. (2008) The effect of simvastatin on remodelling of the alveolar bone following tooth extraction. Int J Oral Max Surg 37: 170–176. doi: 10.1016/j.ijom.2007.06.018
    [54] Sousa FFO, Luzardo-Álvarez A, Pérez-Estévéz A, et al. (2010) Development of a novel AMX-loaded PLGA/zein microsphere for root canal disinfection. Biomed Mater 5: 055008. doi: 10.1088/1748-6041/5/5/055008
    [55] Zhao H, Wu B, Wu H, et al. (2006) Protective immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolic acid) microspheres. Biotechnol Lett 28: 1299–1304. doi: 10.1007/s10529-006-9086-7
    [56] Jamal T, Rahman A, Mirza A, et al. (2012) Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection. Curr Drug Deliv 9: 515–526. doi: 10.2174/156720112802650644
    [57] Chang PC, Dovban AS, Lim LP, et al. (2013) Dual delivery of PDGF and simvastatin to accelerate periodontal regeneration in vivo. Biomaterials 34: 9990–9997. doi: 10.1016/j.biomaterials.2013.09.030
    [58] Brown A, Zaky S, Ray H, et al. (2015) Porous magnesium/PLGA composite scaffolds for enhanced bone regeneration following tooth extraction. Acta Biomater 11: 543–553. doi: 10.1016/j.actbio.2014.09.008
    [59] Van Manen EHC, Zhang W, Walboomers XF, et al. (2014) The influence of electrospun fibre scaffold orientation and nano-hydroxyapatite content on the development of tooth bud stem cells in vitro. Odontology 102: 14–21. doi: 10.1007/s10266-012-0087-9
    [60] Shirakata Y, Nakamura T, Shinohara Y, et al. (2014) An exploratory study on the efficacy of rat dedifferentiated fat cells (rDFATs) with a poly lactic-co-glycolic acid/hydroxylapatite (PLGA/HA) composite for bone formation in a rat calvarial defect model. J Mater Sci-Mater M 25: 899–908. doi: 10.1007/s10856-013-5124-x
    [61] Marei MK, Saad MM, El-Ashwah AM, et al. (2009) Experimental formation of periodontal structure around titanium implants utilizing bone marrow mesenchymal stem cells: a pilot study. J Oral Implantol 35: 106–129. doi: 10.1563/1548-1336-35.3.106
    [62] Akita D, Morokuma M, Saito Y, et al. (2014) Periodontal tissue regeneration by transplantation of rat adipose-derived stromal cells in combination with PLGA-based solid scaffolds. Biomed Res 35: 91–103. doi: 10.2220/biomedres.35.91
    [63] Zhang H, Wang J, Ma H, et al. (2016) Bilayered PLGA/wool keratin composite membranes support periodontal regeneration in beagle dogs. ACS Biomater Sci Eng 2: 2162–2175. doi: 10.1021/acsbiomaterials.6b00357
    [64] Naito Y, Terukina T, Galli S, et al. (2014) The effect of simvastatin-loaded polymeric microspheres in a critical size bone defect in the rabbit calvaria. Int J Pharmaceut 461: 157–162. doi: 10.1016/j.ijpharm.2013.11.046
    [65] Yonamine Y, Matsuyama T, Sonomura T, et al. (2010) Effectable application of vascular endothelial growth factor to critical sized rat calvaria defects. Oral Surg Oral Med O 109: 225–231. doi: 10.1016/j.tripleo.2009.09.010
    [66] Son JS, Choi YA, Park EK, et al. (2013) Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers. J Biomed Mater Res B 101: 247–257.
    [67] Wang F, Song YL, Li CX, et al. (2010) Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol 640: 226–232. doi: 10.1016/j.ejphar.2010.04.024
    [68] Han Y, Zeng Q, Lingling E, et al. (2012) Sustained topical delivery of insulin from fibrin gel loaded with poly(lactic-co-glycolic Acid) microspheres improves the biomechanical retention of titanium implants in type 1 diabetic rats. J Oral Maxil Surg 70: 2299–2308. doi: 10.1016/j.joms.2012.05.028
    [69] Gentile P, Frongia ME, Cardellach M, et al. (2015) Functionalised nanoscale coatings using layer-by-layer assembly for imparting antibacterial properties to polylactide-co-glycolide surfaces. Acta Biomater 21: 35–43. doi: 10.1016/j.actbio.2015.04.009
    [70] Tay FR, Pashley DH, Yiu CKY, et al. (2005) Susceptibility of a polycaprolactone-based root canal filling material to degradation. II. Gravimetric evaluation of enzymatic hydrolysis. J Endodont 31: 737–741.
    [71] Patlolla A, Collins G, Arinzeh TL (2010) Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration. Acta Biomater 6: 90–101. doi: 10.1016/j.actbio.2009.07.028
    [72] Nobile MR, Lucia G, Santella M, et al. (2015) Biodegradable compounds: Rheological, mechanical and thermal properties. AIP Conf Proc 1695: 020058.
    [73] Danhier F, Vroman B, Lecouturier N, et al. (2009) Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release 140: 166–173. doi: 10.1016/j.jconrel.2009.08.011
    [74] Chung S, Ingle NP, Montero GA, et al. (2010) Bioresorbable elastomeric vascular tissue engineering scaffolds via melt spinning and electrospinning. Acta Biomater 6: 1958–1967. doi: 10.1016/j.actbio.2009.12.007
    [75] Guarino V, Ambrosio L (2008) The synergic effect of polylactide fiber and calcium phosphate particle reinforcement in poly epsilon-caprolactone-based composite scaffolds. Acta Biomater 4: 1778–1787. doi: 10.1016/j.actbio.2008.05.013
    [76] Zuo Y, Yang F, Wolke JG, et al. (2010) Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration. Acta Biomater 6: 1238–1247. doi: 10.1016/j.actbio.2009.10.036
    [77] Hayami JW, Surrao DC, Waldman SD, et al. (2010) Design and characterization of a biodegradable composite scaffold for ligament tissue engineering. J Biomed Mater Res A 92: 1407–1420.
    [78] Li WJ, Chiang H, Kuo TF, et al. (2009) Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen M 3: 1–10. doi: 10.1002/term.127
    [79] Nisbet DR, Rodda AE, Horne MK, et al. (2009) Neurite infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into the brain. Biomaterials 30: 4573–4580. doi: 10.1016/j.biomaterials.2009.05.011
    [80] Heydarkhan-Hagvall S, Schenke-Layland K, Dhanasopon AP, et al. (2008) Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials 29: 2907–2914. doi: 10.1016/j.biomaterials.2008.03.034
    [81] Huang MH, Chou AH, Lien SP, et al. (2009) Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-ε-caprolactone). J Biomed Mater Res B 90: 832–841.
    [82] Louvrier A, Euvrard E, Nicod L, et al. (2017) Odontoblastic differentiation of dental pulp stem cells from healthy and carious teeth on an original PCL-based 3D scaffold. Int Endod J 51: e252–e263.
    [83] Chuenjitkuntaworn B, Osathanon T, Nowwarote N, et al. (2016) The efficacy of polycaprolactone/hydroxyapatite scaffold in combination with mesenchymal stem cells for bone tissue engineering. J Biomed Mater Res A 104: 264–271. doi: 10.1002/jbm.a.35558
    [84] Baranowska-Korczyc A, Warowicka A, Jasiurkowska-Delaporte M, et al. (2016) Antimicrobial electrospun poly(ɛ-caprolactone) scaffolds for gingival fibroblast growth. RSC Adv 6: 19647–19656. doi: 10.1039/C6RA02486F
    [85] He S, Timmer MD, Yaszemski MJ, et al. (2001) Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products. Polymer 42: 1251–1260. doi: 10.1016/S0032-3861(00)00479-1
    [86] Christenson EM, Soofi W, Holm JL, et al. (2007) Biodegradable fumarate-based polyHIPEs as tissue engineering scaffolds. Biomacromolecules 8: 3806–3814. doi: 10.1021/bm7007235
    [87] Hacker MC, Haesslein A, Ueda H, et al. (2009) Biodegradable fumarate-based drug-delivery systems for ophthalmic applications. J Biomed Mater Res A 88: 976–989.
    [88] Jayabalan M, Shalumon KT, Mitha MK, et al. (2010) Effect of hydroxyapatite on the biodegradation and biomechanical stability of polyester nanocomposites for orthopaedic applications. Acta Biomater 6: 763–775. doi: 10.1016/j.actbio.2009.09.015
    [89] Mistry AS, Pham QP, Schouten C, et al. (2010) In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering. J Biomed Mater Res A 92: 451–462.
    [90] Trachtenberg JE, Placone JK, Smith BT, et al. (2017) Extrusion-based 3D printing of poly(propylene fumarate) scaffolds with hydroxyapatite gradients. J Biomat Sci-Polym E 28: 532–554. doi: 10.1080/09205063.2017.1286184
    [91] Alge DL, Bennet J, Treasure T, et al. (2012) Poly(propylene fumarate) reinforced dicalcium phosphate dihydrate cement composites for bone tissue engineering. J Biomed Mater Res A 100: 1792–1802.
    [92] Shahabi S, Rezaei Y, Moztarzadeh F, et al. (2016) In vitro degradation and bioactivity of poly(propylene fumarate)/bioactive glass sintered microsphere scaffolds for bone tissue engineering. Sci Eng Compos Mater 23: 245–256.
    [93] Agueros M, Zabaleta V, Espuelas S, et al. (2010) Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J Control Release 145: 2–8. doi: 10.1016/j.jconrel.2010.03.012
    [94] Krasko MY, Golenser J, Nyska A, et al. (2007) Gentamicin extended release from an injectable polymeric implant. J Control Release 117: 90–96. doi: 10.1016/j.jconrel.2006.10.010
    [95] Tamayo I, Irache JM, Mansilla C, et al. (2010) Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation. Clin Vaccine Immunol 17: 1356–1362. doi: 10.1128/CVI.00164-10
    [96] Petersen LK, Sackett CK, Narasimhan B (2010) High-throughput analysis of protein stability in polyanhydride nanoparticles. Acta Biomater 6: 3873–3881. doi: 10.1016/j.actbio.2010.04.004
    [97] Weiner AA, Shuck DM, Bush JR, et al. (2007) In vitro degradation characteristics of photocrosslinked anhydride systems for bone augmentation applications. Biomaterials 28: 5259–5270. doi: 10.1016/j.biomaterials.2007.08.022
    [98] Hasturk H, Kantarci A, Ghattas M, et al. (2014) The use of light/chemically hardened polymethylmethacrylate, polyhydroxylethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants and extraction sockets in minipigs: Part II: histologic and micro-CT evaluations. J Periodontol 85: 1230–1239. doi: 10.1902/jop.2014.120424
    [99] Uhrich KE (2010) Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby. U.S. Patent.
    [100] Zhang Z, Kuijer R, Bulstra SK, et al. (2006) The in vivo and in vitro degradation behavior of poly(trimethylene carbonate). Biomaterials 27: 1741–1748. doi: 10.1016/j.biomaterials.2005.09.017
    [101] Habraken WJ, Zhang Z, Wolke JG, et al. (2008) Introduction of enzymatically degradable poly(trimethylene carbonate) microspheres into an injectable calcium phosphate cement. Biomaterials 29: 2464–2476. doi: 10.1016/j.biomaterials.2008.02.012
    [102] Kluin OS, van der Mei HC, Busscher HJ, et al. (2009) A surface-eroding antibiotic delivery system based on poly-(trimethylene carbonate). Biomaterials 30: 4738–4742. doi: 10.1016/j.biomaterials.2009.05.012
    [103] Bat E, Feijen J, Grijpma DW (2010) Biodegradable elastomeric networks: highly efficient cross-linking of poly(trimethylene carbonate) by gamma irradiation in the presence of pentaerythritol triacrylate. Biomacromolecules 11: 2692–2699. doi: 10.1021/bm1007234
    [104] Chen W, Meng F, Li F, et al. (2009) pH-responsive biodegradable micelles based on acid-labile polycarbonate hydrophobe: synthesis and triggered drug release. Biomacromolecules 10: 1727–1735. doi: 10.1021/bm900074d
    [105] Amsden BG, Timbart L, Marecak D, et al. (2010) VEGF-induced angiogenesis following localized delivery via injectable, low viscosity poly(trimethylene carbonate). J Control Release 145: 109–115. doi: 10.1016/j.jconrel.2010.03.029
    [106] Welle A, Kroger M, Doring M, et al. (2007) Electrospun aliphatic polycarbonates as tailored tissue scaffold materials. Biomaterials 28: 2211–2219. doi: 10.1016/j.biomaterials.2007.01.024
    [107] Suriano F, Pratt R, Tan JP, et al. (2010) Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery. Biomaterials 31: 2637–2645. doi: 10.1016/j.biomaterials.2009.12.022
    [108] Pronych GJ, Sutow EJ, Sykora O (2003) Dimensional stability and dehydration of a thermoplastic polycarbonate-based and two PMMA-based denture resins. J Oral Rehabil 30: 1157–1161. doi: 10.1111/j.1365-2842.2003.01189.x
    [109] Tanimoto Y, Inami T, Yamaguchi M, et al. (2015) Preparation, mechanical, and in vitro properties of glass fiber-reinforced polycarbonate composites for orthodontic application. J Biomed Mater Res B 103: 743–750. doi: 10.1002/jbm.b.33245
    [110] Zhang W, Zhang Z, Chen S, et al. (2016) Mandibular jaw bone regeneration using human dental cell-seeded tyrosine-derived polycarbonate scaffolds. Tissue Eng A 22: 985–993. doi: 10.1089/ten.tea.2016.0166
    [111] Yilgor I, Yilgor E (2007) Structure‐morphology-property behavior of segmented thermoplastic polyurethanes and polyureas prepared without chain extenders. Polym Rev 47: 487–510. doi: 10.1080/15583720701638260
    [112] Asai T, Lee MH, Arrecubieta C, et al. (2007) Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus. J Thorac Cardiov Sur 133: 1147–1153. doi: 10.1016/j.jtcvs.2006.10.084
    [113] Uttayarat P, Perets A, Li M, et al. (2010) Micropatterning of three-dimensional electrospun polyurethane vascular grafts. Acta Biomater 6: 4229–4237. doi: 10.1016/j.actbio.2010.06.008
    [114] Backman S, Bjorling G, Johansson UB, et al. (2009) Material wear of polymeric tracheostomy tubes: a six-month study. Laryngoscope 119: 657–664. doi: 10.1002/lary.20048
    [115] Lavorgna M, Cerruti P, Casula G, et al. (2007) Curing characteristics and mechanical properties of carbon fiber-interlayered fabric composites based on a polyurethane matrix. Adv Polym Tech 26: 132–145. doi: 10.1002/adv.20094
    [116] Kim JH, Kim KB, Kim WC, et al. (2014) Accuracy and precision of polyurethane dental arch models fabricated using a three-dimensional subtractive rapid prototyping method with an intraoral scanning technique. Korean J Orthod 44: 69–76. doi: 10.4041/kjod.2014.44.2.69
    [117] Mampieri G, Giancotti A (2013) Invisalign technique in the treatment of adults with pre-restorative concerns. Prog Orthod 14: 40–40. doi: 10.1186/2196-1042-14-40
    [118] Lee JH, Cho SA (2015) Altered polyurethane cast for a partial removable dental prosthesis. J Prosthet Dent 114: 305–306. doi: 10.1016/j.prosdent.2015.02.011
    [119] Selten MH, Broekema FI, Zuidema J, et al. (2013) Modified polyurethane foam as a local hemostatic agent after dental extractions. Ned Tijdschr Tandheelkd 120: 378–382.
    [120] Ohta T, Tani A, Kimbara K, et al. (2005) A novel nicotinoprotein aldehyde dehydrogenase involved in polyethylene glycol degradation. Appl Microbiol Biot 68: 639–646. doi: 10.1007/s00253-005-1936-z
    [121] Kabanov AV, Lemieux P, Vinogradov S, et al. (2002) Pluronic® block copolymers: novel functional molecules for gene therapy. Adv Drug Deliver Rev 54: 223–233. doi: 10.1016/S0169-409X(02)00018-2
    [122] Aka-Any-Grah A, Bouchemal K, Koffi A, et al. (2010) Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids. Eur J Pharm Biopharm 76: 296–303. doi: 10.1016/j.ejpb.2010.07.004
    [123] Vashi AV, Keramidaris E, Abberton KM, et al. (2008) Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 29: 573–579. doi: 10.1016/j.biomaterials.2007.10.017
    [124] Zhang X, He H, Yen C, et al. (2008) A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies. Biomaterials 29: 4253–4259. doi: 10.1016/j.biomaterials.2008.07.032
    [125] Buxadera-Palomero J, Canal C, Torrent-Camarero S, et al. (2015) Antifouling coatings for dental implants: Polyethylene glycol-like coatings on titanium by plasma polymerization. Biointerphases 10: 029505. doi: 10.1116/1.4913376
    [126] Dabbagh A, Abu Kasim NH, Bakri MM, et al. (2014) Polyethylene-glycol coated maghemite nanoparticles for treatment of dental hypersensitivity. Mater Lett 121: 89–92. doi: 10.1016/j.matlet.2014.01.120
    [127] Mei M, Li QL, Chu C (2016) Inhibition of cariogenic plaque formation on root surface with polydopamine-induced-polyethylene glycol coating. Materials 9: 414. doi: 10.3390/ma9060414
    [128] Thoma DS, Jung UW, Park JY, et al. (2017) Bone augmentation at peri-implant dehiscence defects comparing a synthetic polyethylene glycol hydrogel matrix vs. standard guided bone regeneration techniques. Clin Oral Implan Res 28: e76–e83.
    [129] Walters NJ, Xia W, Salih V, et al. (2016) Poly(propylene glycol) and urethane dimethacrylates improve conversion of dental composites and reveal complexity of cytocompatibility testing. Dent Mater 32: 264–277. doi: 10.1016/j.dental.2015.11.017
    [130] Münchow EA, da Silva AF, da Silveira Lima G, et al. (2015) Polypropylene glycol phosphate methacrylate as an alternative acid-functional monomer on self-etching adhesives. J Dent 43: 94–102. doi: 10.1016/j.jdent.2014.11.005
    [131] Diniz IMA, Chen C, Xu X, et al. (2015) Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells. J Mater Sci-Mater M 26: 153. doi: 10.1007/s10856-015-5493-4
    [132] Mogen AB, Chen F, Ahn SJ, et al. (2015) Pluronics-formulated farnesol promotes efficient killing and demonstrates novel interactions with Streptococcus mutans biofilms. PLoS One 10: e0133886. doi: 10.1371/journal.pone.0133886
    [133] Ramshaw JA, Shah NK, Brodsky B (1998) Gly-X-Y tripeptide frequencies in collagen: a context for host-guest triple-helical peptides. J Struct Biol 122: 86–91. doi: 10.1006/jsbi.1998.3977
    [134] Krane SM (2008) The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35: 703–710. doi: 10.1007/s00726-008-0073-2
    [135] Yilmaz N, Inal S, Muglali M, et al. (2010) Effects of polyglecaprone 25, silk and catgut suture materials on oral mucosa wound healing in diabetic rats: an evaluation of nitric oxide dynamics. Med Oral Patol Oral 15: e526–e530.
    [136] Friberg O, Dahlin LG, Kallman J, et al. (2009) Collagen-gentamicin implant for prevention of sternal wound infection; long-term follow-up of effectiveness. Interact Cardiov Th 9: 454–458. doi: 10.1510/icvts.2009.207514
    [137] Holladay C, Keeney M, Greiser U, et al. (2009) A matrix reservoir for improved control of non-viral gene delivery. J Control Release 136: 220–225. doi: 10.1016/j.jconrel.2009.02.006
    [138] Vinas-Castells R, Holladay C, di Luca A, et al. (2009) Snail1 down-regulation using small interfering RNA complexes delivered through collagen scaffolds. Bioconjugate Chem 20: 2262–2269. doi: 10.1021/bc900241w
    [139] Maehara H, Sotome S, Yoshii T, et al. (2010) Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2). J Orthop Res 28: 677–686.
    [140] Baik SH, Kim JH, Cho HH, et al. (2010) Development and analysis of a collagen-based hemostatic adhesive. J Surg Res 164: e221–e228. doi: 10.1016/j.jss.2010.08.004
    [141] Wang L, Stegemann JP (2010) Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials 31: 3976–3985. doi: 10.1016/j.biomaterials.2010.01.131
    [142] Yan LP, Wang YJ, Ren L, et al. (2010) Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications. J Biomed Mater Res A 95: 465–475.
    [143] Casper CL, Yang W, Farach-Carson MC, et al. (2007) Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules 8: 1116–1123. doi: 10.1021/bm061003s
    [144] Ciardelli G, Gentile P, Chiono V, et al. (2010) Enzymatically crosslinked porous composite matrices for bone tissue regeneration. J Biomed Mater Res A 92: 137–151.
    [145] Kim JY, Xin X, Moioli EK, et al. (2010) Regeneration of dental-pulp-like tissue by chemotaxis-induced cell homing. Tissue Eng A 16: 3023–3031. doi: 10.1089/ten.tea.2010.0181
    [146] Tatakis DN, Promsudthi A, Wikesjö UME (1999) Devices for periodontal regeneration. Periodontol 2000 19: 59–73. doi: 10.1111/j.1600-0757.1999.tb00147.x
    [147] Chatzistavrou X, Rao RR, Caldwell DJ, et al. (2016) Collagen/fibrin microbeads as a delivery system for Ag-doped bioactive glass and DPSCs for potential applications in dentistry. J Non-Cryst Solids 432: 143–149. doi: 10.1016/j.jnoncrysol.2015.03.024
    [148] Kothapalli CR, Ramamurthi A (2010) Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair. Acta Biomater 6: 170–178. doi: 10.1016/j.actbio.2009.06.006
    [149] Mithieux SM, Rasko JE, Weiss AS (2004) Synthetic elastin hydrogels derived from massive elastic assemblies of self-organized human protein monomers. Biomaterials 25: 4921–4927. doi: 10.1016/j.biomaterials.2004.01.055
    [150] Kaufmann D, Weberskirch R (2006) Efficient synthesis of protein-drug conjugates using a functionalizable recombinant elastin-mimetic polypeptide. Macromol Biosci 6: 952–958. doi: 10.1002/mabi.200600117
    [151] Tu Y, Wise SG, Weiss AS (2010) Stages in tropoelastin coalescence during synthetic elastin hydrogel formation. Micron 41: 268–272. doi: 10.1016/j.micron.2009.11.003
    [152] Gurumurthy B, Bierdeman PC, Janorkar AV (2016) Composition of elastin like polypeptide–collagen composite scaffold influences in vitro osteogenic activity of human adipose derived stem cells. Dent Mater 32: 1270–1280. doi: 10.1016/j.dental.2016.07.009
    [153] Amruthwar SS, Janorkar AV (2013) In vitro evaluation of elastin-like polypeptide–collagen composite scaffold for bone tissue engineering. Dent Mater 29: 211–220. doi: 10.1016/j.dental.2012.10.003
    [154] Shaikh FM, Callanan A, Kavanagh EG, et al. (2008) Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188: 333–346. doi: 10.1159/000139772
    [155] Choukroun J, Diss A, Simonpieri A, et al. (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med O 101: e56–60.
    [156] Li Q, Pan S, Dangaria SJ, et al. (2013) Platelet-rich fibrin promotes periodontal regeneration and enhances alveolar bone augmentation. BioMed Res Int 2013: 638043.
    [157] Marenzi G, Riccitiello F, Tia M, et al. (2015) Influence of leukocyte- and platelet-rich fibrin (L-PRF) in the healing of simple postextraction sockets: a split-mouth study. BioMed Res Int 2015: 369273.
    [158] Keswani D, Pandey RK (2013) Revascularization of an immature tooth with a necrotic pulp using platelet-rich fibrin: a case report. Int Endod J 46: 1096–1104.
    [159] Zhao YH, Zhang M, Liu NX, et al. (2013) The combined use of cell sheet fragments of periodontal ligament stem cells and platelet-rich fibrin granules for avulsed tooth reimplantation. Biomaterials 34: 5506–5520. doi: 10.1016/j.biomaterials.2013.03.079
    [160] Dohan Ehrenfest DM, Del Corso M, Diss A, et al. (2010) Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 81: 546–555. doi: 10.1902/jop.2009.090531
    [161] Portilla-Arias JA, Camargo B, Garcia-Alvarez M, et al. (2009) Nanoparticles made of microbial poly(gamma-glutamate)s for encapsulation and delivery of drugs and proteins. J Biomat Sci Polym E 20: 1065–1079. doi: 10.1163/156856209X444420
    [162] Takehara M, Hibino A, Saimura M, et al. (2010) High-yield production of short chain length poly(epsilon-L-lysine) consisting of 5–20 residues by Streptomyces aureofaciens, and its antimicrobial activity. Biotechnol Lett 32: 1299–1303. doi: 10.1007/s10529-010-0294-9
    [163] Tang CK, Sheng KC, Pouniotis D, et al. (2008) Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses. Vaccine 26: 3827–3834. doi: 10.1016/j.vaccine.2008.05.008
    [164] Kim SS, Seo M, Chung JW, et al. (2009) Polymeric calcium phosphate cements incorporated with poly-γ-glutamic acid: Comparative study of poly-γ-glutamic acid and citric acid. J Appl Polym Sci 113: 1223–1231. doi: 10.1002/app.30037
    [165] Varoni E, Canciani E, Palazzo B, et al. (2015) Effect of Poly-L-Lysine coating on titanium osseointegration: from characterization to in vivo studies. J Oral Implantol 41: 626–631. doi: 10.1563/AAID-JOI-D-13-00036
    [166] Walters NJ, Palmer G, Ashley PF, et al. (2015) Monocalcium phosphate induces greater hydroxyapatite mineral formation than tricalcium phosphate on dental composites containing ε-poly-L-lysine. TERMIS-WC 2015, Proceedings of Tissue Engineering & Regenerative Medicine International Society World Congress, Boston, MA, USA.
    [167] Chen L, Tian H, Chen J, et al. (2010) Multi-armed poly(L-glutamic acid)-graft-oligoethylenimine copolymers as efficient nonviral gene delivery vectors. J Gene Med 12: 64–76. doi: 10.1002/jgm.1405
    [168] Pilbat AM, Ball V, Schaaf P, et al. (2006) Partial poly(glutamic acid) ↔ poly(aspartic acid) exchange in layer-by-layer polyelectrolyte films. Structural alterations in the three-component architectures. Langmuir 22: 5753–5759.
    [169] Karal-Yilmaz O, Kayaman-Apohan N, Misirli Z, et al. (2006) Synthesis and characterization of poly(L-lactic acid-co-ethylene oxide-co-aspartic acid) and its interaction with cells. J Mater Sci-Mater M 17: 213–227. doi: 10.1007/s10856-006-7307-1
    [170] Benkirane-Jessel N, Palomares CM, Fioretti F (2014) Compound comprising alpha-msh for use in endodontic regeneration. U.S. Patent.
    [171] Osorio R, Sauro S (2015) Polyaspartic acid enhances dentine remineralization bonded with a zinc-doped Portland-based resin cement. Int Endod J 49: 874–883.
    [172] Wang X, Ji J (2009) Postdiffusion of oligo-peptide within exponential growth multilayer films for localized peptide delivery. Langmuir 25: 11664–11671. doi: 10.1021/la9013575
    [173] Pasquinelli G, Orrico C, Foroni L, et al. (2008) Mesenchymal stem cell interaction with a non-woven hyaluronan-based scaffold suitable for tissue repair. J Anat 213: 520–530. doi: 10.1111/j.1469-7580.2008.00974.x
    [174] Temiz A, Kazikdas KC, Ergur B, et al. (2010) Esterified hyaluronic acid improves cartilage viability in experimental tracheal reconstruction with an auricular graft. Otolaryng Head Neck 143: 772–778. doi: 10.1016/j.otohns.2010.07.007
    [175] Grigolo B, Lisignoli G, Desando G, et al. (2009) Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng C 15: 647–658. doi: 10.1089/ten.tec.2008.0569
    [176] Pandis L, Zavan B, Abatangelo G, et al. (2010) Hyaluronan-based scaffold for in vivo regeneration of the rat vena cava: Preliminary results in an animal model. J Biomed Mater Res A 93: 1289–1296.
    [177] Zavan B, Abatangelo G, Mazzoleni F, et al. (2008) New 3D hyaluronan-based scaffold for in vitro reconstruction of the rat sciatic nerve. Neurol Res 30: 190–196. doi: 10.1179/174313208X281082
    [178] El-Sayed KMF, Dahaba MA, Aboul-Ela S, et al. (2012) Local application of hyaluronan gel in conjunction with periodontal surgery: a randomized controlled trial. Clin Oral Invest 16: 1229–1236. doi: 10.1007/s00784-011-0630-z
    [179] Gontiya G, Galgali SR (2012) Effect of hyaluronan on periodontitis: A clinical and histological study. J Indian Soc Periodontol 16: 184–192. doi: 10.4103/0972-124X.99260
    [180] Chrepa V, Austah O, Diogenes A (2017) Evaluation of a commercially available hyaluronic acid hydrogel (restylane) as injectable scaffold for dental pulp regeneration: an in vitro evaluation. J Endodont 43: 257–262. doi: 10.1016/j.joen.2016.10.026
    [181] Ferroni L, Gardin C, Sivolella S, et al. (2015) A hyaluronan-based scaffold for the in vitro construction of dental pulp-like tissue. Int J Mol Sci 16: 4666. doi: 10.3390/ijms16034666
    [182] Tan L, Wang J, Yin S, et al. (2015) Regeneration of dentin-pulp-like tissue using an injectable tissue engineering technique. RSC Adv 5: 59723–59737. doi: 10.1039/C5RA06481C
    [183] Xia W, Liu P, Liu J (2008) Advance in chitosan hydrolysis by non-specific cellulases. Bioresource Technol 99: 6751–6762. doi: 10.1016/j.biortech.2008.01.011
    [184] Li DH, Liu LM, Tian KL, et al. (2007) Synthesis, biodegradability and cytotoxicity of water-soluble isobutylchitosan. Carbohyd Polym 67: 40–45. doi: 10.1016/j.carbpol.2006.04.022
    [185] Park CJ, Gabrielson NP, Pack DW, et al. (2009) The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-8. Biomaterials 30: 436–444. doi: 10.1016/j.biomaterials.2008.09.060
    [186] Burkatovskaya M, Tegos GP, Swietlik E, et al. (2006) Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials 27: 4157–4164. doi: 10.1016/j.biomaterials.2006.03.028
    [187] Wu L, Li H, Li S, et al. (2010) Composite fibrous membranes of PLGA and chitosan prepared by coelectrospinning and coaxial electrospinning. J Biomed Mater Res A 92: 563–574.
    [188] Azab AK, Orkin B, Doviner V, et al. (2006) Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis. J Control Release 111: 281–289. doi: 10.1016/j.jconrel.2005.12.014
    [189] Wang J, Feng SS, Wang S, et al. (2010) Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment. Int J Pharmaceut 400: 194–200. doi: 10.1016/j.ijpharm.2010.08.026
    [190] Sarukawa J, Takahashi M, Abe M, et al. (2011) Effects of chitosan-coated fibers as a scaffold for three-dimensional cultures of rabbit fibroblasts for ligament tissue engineering. J Biomat Sci Polym E 22: 717–732. doi: 10.1163/092050610X491067
    [191] Busscher HJ, Engels E, Dijkstra RJB, et al. (2008) Influence of a chitosan on oral bacterial adhesion and growth in vitro. Eur J Oral Sci 116: 493–495. doi: 10.1111/j.1600-0722.2008.00568.x
    [192] Barreras US, Mendez FT, Martinez RE, et al. (2016) Chitosan nanoparticles enhance the antibacterial activity of chlorhexidine in collagen membranes used for periapical guided tissue regeneration. Mat Sci Eng C-Mater 58: 1182–1187. doi: 10.1016/j.msec.2015.09.085
    [193] Elsaka SE (2012) Antibacterial activity and adhesive properties of a chitosan-containing dental adhesive. Quintessence Int 43: 603–613.
    [194] Mota J, Yu N, Caridade SG, et al. (2012) Chitosan/bioactive glass nanoparticle composite membranes for periodontal regeneration. Acta Biomater 8: 4173–4180. doi: 10.1016/j.actbio.2012.06.040
    [195] Tan CS, Jejurikar A, Rai B, et al. (2009) Encapsulation of a glycosaminoglycan in hydroxyapatite/alginate capsules. J Biomed Mater Res A 91: 866–877.
    [196] Liu XY, Nothias JM, Scavone A, et al. (2010) Biocompatibility investigation of polyethylene glycol and alginate-poly-L-lysine for islet encapsulation. ASAIO J 56: 241–245. doi: 10.1097/MAT.0b013e3181d7b8e3
    [197] Giovagnoli S, Tsai T, DeLuca PP (2010) Formulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained delivery. AAPS PharmSciTech 11: 212–220. doi: 10.1208/s12249-009-9361-8
    [198] Jay SM, Shepherd BR, Andrejecsk JW, et al. (2010) Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31: 3054–3062. doi: 10.1016/j.biomaterials.2010.01.014
    [199] Qi J, Chen A, You H, et al. (2011) Proliferation and chondrogenic differentiation of CD105-positive enriched rat synovium-derived mesenchymal stem cells in three-dimensional porous scaffolds. Biomed Mater 6: 015006. doi: 10.1088/1748-6041/6/1/015006
    [200] Meng X, Li P, Wei Q, et al. (2011) pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery. Pharm Dev Technol 16: 22–28. doi: 10.3109/10837450903479947
    [201] Wittmer CR, Phelps JA, Lepus CM, et al. (2008) Multilayer nanofilms as substrates for hepatocellular applications. Biomaterials 29: 4082–4090. doi: 10.1016/j.biomaterials.2008.06.027
    [202] Lee JW, Park YJ, Lee SJ, et al. (2010) The effect of spacer arm length of an adhesion ligand coupled to an alginate gel on the control of fibroblast phenotype. Biomaterials 31: 5545–5551. doi: 10.1016/j.biomaterials.2010.03.063
    [203] Moshaverinia A, Chen C, Xu X, et al. (2014) Bone regeneration potential of stem cells derived from periodontal ligament or gingival tissue sources encapsulated in RGD-modified alginate scaffold. Tissue Eng A 20: 611–621. doi: 10.1089/ten.tec.2013.0408
    [204] Srinivasan S, Jayasree R, Chennazhi KP, et al. (2012) Biocompatible alginate/nano bioactive glass ceramic composite scaffolds for periodontal tissue regeneration. Carbohyd Polym 87: 274–283. doi: 10.1016/j.carbpol.2011.07.058
    [205] Mattamal GJ (2008) US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives. Expert Rev Med Devic 5: 41–49. doi: 10.1586/17434440.5.1.41
  • This article has been cited by:

    1. Xiaozhou Feng, Kunyu Li, Haixia Li, Bifurcation and stability analysis of a Leslie–Gower diffusion predator–prey model with prey refuge and Beddington–DeAngelis functional response, 2024, 0170-4214, 10.1002/mma.10470
    2. Sangeeta Kumari, Sidharth Menon, Abhirami K, Dynamical system of quokka population depicting Fennecaphobia by Vulpes vulpes, 2025, 22, 1551-0018, 1342, 10.3934/mbe.2025050
  • Reader Comments
  • © 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(9758) PDF downloads(1838) Cited by(26)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog